YOUNG KEVIN 4
4 · Cortexyme, Inc. · Filed Jun 9, 2020
Insider Transaction Report
Form 4
Cortexyme, Inc.CRTX
YOUNG KEVIN
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-08+11,029→ 11,029 totalExercise: $41.73Exp: 2030-06-07→ Common Stock (11,029 underlying)
Footnotes (1)
- [F1]This option shall fully vest on the one-year anniversary of the grant date, subject to the reporting person's continued services as a member of the board of directors of Cortexyme, Inc. through such vesting date.